Journalistic reporting of 'miraculous' pre-clinical results hasn't changed much in 100 years it seems. Of course, we aren't using trypsin to treat cancer today.
Nevertheless, we should be optimistic, we live during a golden age for the life sciences.
What I find disappointing is that this work has been spirited away to a VC funded private company. At best they will fail, at worst they will stop others from making progress.
Re:Destroying worn-out cells makes mice live longer
by jostmey on Wednesday February 03, 2016 @08:04PM
(#11031239)
Private funding is great for engineering projects. But it is only useful in scientific endeavors when the scientist can talk with the academic community openly.
Journalistic reporting of 'miraculous' pre-clinical results hasn't changed much in 100 years it seems. Of course, we aren't using trypsin to treat cancer today.
Nevertheless, we should be optimistic, we live during a golden age for the life sciences.
What I find disappointing is that this work has been spirited away to a VC funded private company. At best they will fail, at worst they will stop others from making progress.